The FDA has approved Johnson & Johnson’s supplemental new drug application for Caplyta among patients with schizophrenia at ...

In today's ACT Brief, we examine governance inertia when AI accelerates protocol development, why payment experience is ...

RIVERSIDE, Calif. – Resurgence Behavioral Health in Riverside announced the release of its latest educational article, “How Can You Use the Five Rules of Recovery to Stay Sober?”, offering practical ...

All In Solutions California, a premier addiction treatment center, has reinforced its commitment to equipping clients with comprehensive relapse prevention tools designed to support sustainable ...

The holidays can be especially stressful for people in recovery, with disrupted routines and social pressure increasing the risk of relapse. Experts say having a holiday relapse prevention plan can ...

New research highlights how AI-powered monitoring, digital therapeutics, and online recovery tools are transforming relapse prevention for addiction and mental health. Studies show these technologies ...

FDA label expansion adds relapse-prevention in adult schizophrenia, addressing a major driver of hospitalization, functional ...